Financials Chugai Pharmaceutical Co., Ltd.

Equities

4519

JP3519400000

Pharmaceuticals

Delayed Japan Exchange Other stock markets 06:30:00 19/01/2026 GMT			5-day change	1st Jan Change
8,228.00 ^JPY	-0.29%		-2.29%	-0.18%

12-30	Chugai Completes Merger With Renalys Pharma	MT
12-29	Chugai Pharmaceutical Co., Ltd. completed the acquisition of Renalys Pharma.	CI

Projected Income Statement: Chugai Pharmaceutical Co., Ltd.

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net sales ¹	786,900	999,800	1,259,946	1,111,367	1,170,611	1,247,911	1,333,977	1,450,707
Change	-	27.06%	26.02%	-11.79%	5.33%	6.6%	6.9%	8.75%
EBITDA ¹	332,600	459,100	565,376	470,914	573,667	635,761	680,483	774,818
Change	-	38.03%	23.15%	-16.71%	21.82%	10.82%	7.03%	13.86%
EBIT ¹	301,200	421,900	533,309	439,174	542,002	594,966	663,767	749,534
Change	-	40.07%	26.41%	-17.65%	23.41%	9.77%	11.56%	12.92%
Interest Paid ¹	-1,539	-48	-61	-27	-	-1,068	-30	-33
Earnings before Tax (EBT) ¹	298,200	419,400	531,166	443,821	543,034	595,235	670,840	762,469
Change	-	40.64%	26.65%	-16.44%	22.35%	9.61%	12.7%	13.66%
Net income ¹	214,700	303,000	374,429	325,472	387,317	428,644	483,253	546,647
Change	-	41.13%	23.57%	-13.08%	19%	10.67%	12.74%	13.12%
Announcement Date	04/02/21	03/02/22	02/02/23	01/02/24	30/01/25	-	-	-

¹JPY in Million

Estimates

Fiscal Period: December	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2027 Q1
Net sales ¹	208,400	210,400	168,817	221,412	287,264	322,300	360,554	235,600	225,300	438,446	312,240	267,417	257,898	273,812	236,900	315,911	315,700	302,111	288,500	290,004	333,200	322,212	283,000	303,000
Change	-	0.96%	-19.76%	31.16%	29.74%	12.2%	11.87%	-34.66%	-4.37%	94.61%	-28.78%	-14.36%	-3.56%	6.17%	-13.48%	33.35%	-0.07%	-4.3%	-4.51%	0.52%	14.89%	-3.3%	-12.17%	7.07%
EBITDA ¹	-	-	-	-	-	-	-	-	-	-	-	-	-	131,116	107,900	166,021	169,300	31,665	144,700	144,740	176,300	126,900	-	-
Change	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-17.71%	53.87%	1.98%	-81.3%	356.97%	0.03%	21.8%	-28.02%	-	-
EBIT ¹	86,689	73,900	63,967	96,712	122,156	139,100	187,007	99,900	96,900	149,509	98,296	112,614	106,688	121,576	99,900	158,321	160,400	123,402	136,700	136,691	156,500	161,370	137,700	153,300
Change	-	-14.75%	-13.44%	51.19%	26.31%	13.87%	34.44%	-46.58%	-3%	54.29%	-34.25%	14.57%	-5.26%	13.95%	-17.83%	58.48%	1.31%	-23.07%	10.78%	-0.01%	14.49%	3.11%	-14.67%	11.33%
Charge d'intérêts	-853	-506	-12	-	-12	-	-14	-	-16	-16	-2	-	-8	-	-	-	-1,079	-	-822	-	-413	-	-	-
Earnings before Tax (EBT) ¹	85,573	73,100	64,240	97,016	119,689	138,400	186,206	100,700	95,000	149,266	99,662	113,994	107,475	122,690	99,900	158,801	158,800	124,400	135,800	136,001	156,100	154,326	138,000	153,600
Change	-	-14.58%	-12.12%	51.02%	23.37%	15.63%	34.54%	-45.92%	-5.66%	57.12%	-33.23%	14.38%	-5.72%	14.16%	-18.58%	58.96%	-0%	-21.66%	9.16%	0.15%	14.78%	-1.14%	-10.58%	11.3%
Net income ¹	60,132	52,300	47,411	70,726	86,017	98,800	131,775	72,400	67,800	102,429	73,500	83,193	77,573	91,206	74,400	111,861	109,500	91,517	97,200	97,155	111,200	108,970	98,300	109,400
Change	-	-13.02%	-9.35%	49.18%	21.62%	14.86%	33.38%	-45.06%	-6.35%	51.08%	-28.24%	13.19%	-6.76%	17.57%	-18.43%	50.35%	-2.11%	-16.42%	6.21%	-0.05%	14.46%	-2.01%	-9.79%	11.29%
Announcement Date	22/10/20	04/02/21	22/04/21	26/07/21	22/10/21	03/02/22	25/04/22	21/07/22	24/10/22	02/02/23	27/04/23	27/07/23	24/10/23	01/02/24	24/04/24	25/07/24	25/10/24	30/01/25	24/04/25	24/07/25	24/10/25	-	-	-

¹JPY in Million

Estimates

Fiscal Period: December	2021 S1	2022 S1	2023 S1	2024 S1	2025 S1	2026 S1	2027 S1
Net sales ¹	390,229	596,200	579,657	552,860	578,463	616,000	647,000
Change	-	52.78%	-2.77%	-4.62%	4.63%	6.49%	5.03%
EBITDA	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-
EBIT ¹	160,679	286,900	210,910	258,195	273,342	310,400	337,400
Change	-	78.55%	-26.49%	22.42%	5.87%	13.56%	8.7%
Charge d'intérêts	-24	-29	-11	-	-1,512	-	-
Earnings before Tax (EBT) ¹	161,256	286,900	213,656	258,690	271,830	310,900	337,900
Change	-	77.92%	-25.53%	21.08%	5.08%	14.37%	8.68%
Net income ¹	118,137	204,200	156,693	186,262	194,389	221,900	241,400
Change	-	72.85%	-23.26%	18.87%	4.36%	14.15%	8.79%
Announcement Date	26/07/21	21/07/22	27/07/23	25/07/24	24/07/25	-	-

¹JPY in Million

Estimates

Forecast Balance Sheet: Chugai Pharmaceutical Co., Ltd.

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net Debt ¹	-378,620	-472,000	-488,998	-738,982	-996,345	-869,917	-1,094,126	-1,353,688
Change	-	-24.66%	-3.6%	-51.12%	-34.83%	12.69%	-25.77%	-23.72%
Announcement Date	04/02/21	03/02/22	02/02/23	01/02/24	30/01/25	-	-	-

¹JPY in Million

Estimates

Cash Flow Forecast: Chugai Pharmaceutical Co., Ltd.

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
CAPEX ¹	57,040	65,969	61,800	71,948	50,415	68,371	69,560	68,401
Change	-	15.65%	-6.32%	16.42%	-29.93%	35.62%	1.74%	-1.67%
Free Cash Flow (FCF) ¹	106,723	160,699	182,312	372,635	220,235	335,536	431,416	507,307
Change	-	50.58%	13.45%	104.39%	-40.9%	52.35%	28.58%	17.59%
Announcement Date	04/02/21	03/02/22	02/02/23	01/02/24	30/01/25	-	-	-

¹JPY in Million

Estimates

Forecast Financial Ratios: Chugai Pharmaceutical Co., Ltd.

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Profitability
EBITDA Margin (%)	42.27%	45.92%	44.87%	42.37%	49.01%	50.95%	51.01%	53.41%
EBIT Margin (%)	38.28%	42.2%	42.33%	39.52%	46.3%	47.68%	49.76%	51.67%
EBT Margin (%)	37.9%	41.95%	42.16%	39.93%	46.39%	47.7%	50.29%	52.56%
Net margin (%)	27.28%	30.31%	29.72%	29.29%	33.09%	34.35%	36.23%	37.68%
FCF margin (%)	13.56%	16.07%	14.47%	33.53%	18.81%	26.89%	32.34%	34.97%
FCF / Net Income (%)	49.71%	53.04%	48.69%	114.49%	56.86%	78.28%	89.27%	92.8%
Profitability
ROA	25.99%	30.23%	31.17%	23.34%	18.71%	19.14%	20.46%	20.83%
ROE	23.4%	28%	28.7%	21.3%	22%	22.34%	23.57%	23.41%
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	7.25%	6.6%	4.9%	6.47%	4.31%	5.48%	5.21%	4.72%
CAPEX / EBITDA (%)	17.15%	14.37%	10.93%	15.28%	8.79%	10.75%	10.22%	8.83%
CAPEX / FCF (%)	53.45%	41.05%	33.9%	19.31%	22.89%	20.38%	16.12%	13.48%
Items per share
Cash flow per share ¹	149.1	203.1	246.8	217.1	254.6	280.7	313.9	358.2
Change	-	36.15%	21.52%	-12.01%	17.28%	10.25%	11.81%	14.12%
Dividend per Share ¹	55	76	78	80	98	253.8	128.6	145.3
Change	-	38.18%	2.63%	2.56%	22.5%	158.93%	-49.33%	12.98%
Book Value Per Share ¹	596.2	722.5	865.9	988	1,156	1,200	1,336	1,527
Change	-	21.19%	19.84%	14.1%	16.96%	3.81%	11.38%	14.32%
EPS ¹	130.7	184.3	227.6	197.8	235.4	260.4	293.7	332.2
Change	-	41.05%	23.52%	-13.1%	18.99%	10.63%	12.77%	13.12%
Nbr of stocks (in thousands)	1,643,817	1,644,260	1,645,014	1,645,274	1,645,514	1,645,705	1,645,705	1,645,705
Announcement Date	04/02/21	03/02/22	02/02/23	01/02/24	30/01/25	-	-	-